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C57BL/6, BALB/c, and CBA/Ca mouse strains with different MHC-I haplotypes were compared with respect to susceptibility to
Neospora caninum infection. Groups of 5 mice received 1 × 106, 5 × 106, or 25 × 106 tachyzoites of the NC-Liverpool isolate by
intraperitoneal injection andwere observed for disease symptoms.Humoral responses, splenocyte interferon-𝛾 (IFN-𝛾) production,
cerebral parasite loads, and histopathology were evaluated at human end points or the latest at 34 days postinfection (PI). The
mortality rates in C57BL/6mice were the highest, and relatively high levels of IgG1 antibodies were detected in thosemice surviving
till 34 days PI. In lymphocyte proliferation assays, spleen cells from C57BL6 mice stimulated with N. caninum antigen extract
exhibited large variations in IFN-𝛾 production. In BALB/c mice mortality was 0% at the lowest and 100% at the highest infection
dose. Serologically they responded with high levels of both IgG2a and IgG1 subclasses, and lymphocyte proliferation assays of
surviving mice yielded lower IFN-𝛾 levels. CBA/Ca mice were the most resistant, with no animal succumbing to infection at a dose
of 1 × 106 and 5 × 106 tachyzoites, but 100% mortality at 25 × 106 tachyzoites. High IgG2a levels as well as increased IFN-𝛾 in
lymphocyte proliferation assays were measured in CBA/Ca mice infected with 1 × 106 tachyzoites.
1. Introduction
Neospora caninum is an apicomplexan protozoan, infecting
a large range of mammals. In cattle, this parasite represents
a major cause of abortion [1–3]. Several studies focussing
on the specific immune response to N. caninum in cattle
have shown that the time of gestation is important with
regard to the outcome of the infection.This may be explained
on the basis of hormone levels and cytokine profiles [4].
Proinflammatory cytokines, produced by lymphocytes, are
crucial for controlling a variety of intracellular pathogens,
including N. caninum. These cytokines are produced by
natural killer (NK) cells, as well as by CD4+ T-cells and
CD8+ T-cells. CD4+ cells mediate the humoral response and
their involvement is associated with increased IgG1 levels,
whereas CD8+ cells are involved in the cellular immune
response, which is characterized by increased production of
IgG2a. Indeed, both has been observed in experimentally and
naturally infected animals [5].
N. caninum is an intracellular parasite and resides within
a specialized compartment, a parasitophorous vacuole, sur-
rounded by a parasitophorous vacuole membrane (PVM).
Following egress from a host cell, these parasites immediately
search for a new host cell to invade, and the direct accessi-
bility for components of the immune system to the parasite
within the circulation is rather limited. Thus, extracellular
tachyzoites have a low chance to be detected by T-helper-2-
(Th2-) type cells. A humoral immune response is there-
fore not sufficient to clear a N. caninum infection. For
more efficient protection against intracellular pathogens
such as N. caninum, the host usually generates a cellular,s
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T-helper-1-(Th1-) type response [6, 7]. This is possible since
secretory parasite molecules pass through the PVM into the
host cell cytoplasm, where they interact with and manipulate
host cell functions [8]. Once in the cytoplasm thesemolecules
can be processed and corresponding peptides are presented
on the host cell surface via major histocompatibility complex
(MHC) class I molecules. CD8+ lymphocytes will recog-
nize the peptides presented on these MHC-I molecules
and activate Th1 cells, which then produce cytokines such
as interleukin-12 (IL-12), interferon gamma (IFN-𝛾), and
tumour necrosis factor 𝛼 (TNF-𝛼). The production of these
cytokines leads to the activation of pathways that generate
free oxygen radicals and nitric oxide (NO) and itsmetabolites
among other factors, which are potentially lethal for many
protozoa [9].
However, these processes can also be deleterious to
the fetoplacental interface and potentially induce abortion
and/or fetal resorption [10], especially in the first trimester
of pregnancy, when levels of pregnancy hormones, such as
progesterone, which counteracts these effects, are relatively
low.As a result, there is no or only littleTh2 cytokine polariza-
tion and the damwill generate aTh1 immune response, which
also affects the placental and foetal tissue. Since a strong
Th1 response is incompatible with successful pregnancy, the
infection can lead to the loss of the unborn foetus. If the
infection occurs in the third trimester, progesterone levels
are high. Progesterone promotes Th2 cell proliferation the
production of IL-4, IL-5, and IL-10 is known to inhibit NO
and TNF-𝛼 production and impairs NK cell activity [11–
13]. The risk of abortion due to a Th2 response is therefore
relatively low. However, since the immune response is not
capable of controlling the parasite, the risk of transplacental
transmission of N. caninum is relatively high [14]. Thus,
resistance to N. caninum seems to rely, at least partially, on
a functional Th1 response.
In this study, inbred BALB/c, CBA/Ca, and C57BL/6
strains of mice (with different MHC-I haplotypes) were
compared for their capacity to cope with a N. caninum
infection. We found different outcomes of infections in the
three models. In addition, we show that CBA/Ca mice were
the by far most resistant, and protection correlated with the
induction of a Th1-biased response. The results demonstrate
that a meaningful evaluation of the efficacy of, for example,
vaccine candidates and/or chemotherapeutically interesting
compounds against experimental infection with N. caninum
in mice requires standardization with regard to the mouse
strains used for such experiments.
2. Materials and Methods
2.1. Mice and Housing Conditions. Female BALB/c, CBA/Ca,
and C57BL/6 mice aged 8–12 weeks were obtained fromHar-
lan (Horst, The Netherlands). Mice were randomly divided
into groups as soon as they came to hand and marked
individually. The conditions in the animal housing facilities
were negative air pressure, air exchange of 300m3/hr, tem-
perature of 22∘C ± 2∘C, and artificial day/night cycle with
12 hrs light per day. Five mice were housed per group in
Macrolon Type III cages (820 cm2) enriched with polyvinyl
chloride tubes and tissues. Tissues and Type GS bedding
material were refreshed at least once per two weeks. Mice
received ad libitum standard rodent feed (RMHB2118, AB-
diets Woerden, The Netherlands). Water was supplied in
bottles and refreshed at least three times a week. Prior to
challenge, mice were given an acclimatization period of 7
days, during which they were observed daily for normal
behaviour, wellness, food and water intake, and posture.
2.2. N. caninum Tachyzoite Culture. N. caninum tachyzoites
(NC-Liv isolate) were maintained by continuous passages
in Vero cells grown in RPMI 1640 medium supplemented
with 10% foetal bovine serum (FBS), 2mM L-glutamine
and 25mg/L gentamycin sulphate. Cultures were grown in
a humidified incubator at 37∘C with 5% CO
2
. To liberate
the tachyzoites from the Vero cells, the culture was taken
up through a 20G needle and extruded through a 26G
needle. For the preparation of parasites for infection, tachy-
zoites were purified on a PD10 column (GE Healthcare,
Diegem, Belgium) centrifuged and resuspended in sterile
0.04M isotonic PBS. Tachyzoites were counted in aNeubauer
chamber. In order to prepare N. caninum tachyzoite antigen
lysate, purified tachyzoites were subjected to one freeze-thaw
cycle followed by sonication on a Branson Sonifier S-250A
(Branson ultrasonics, Danbury, USA) for 60 sec, output 4,
and a cycle duty of 50%. The antigenic solution was divided
into aliquots and stored at −20∘C until further use.
2.3. Experimental Infection of Mice and Subsequent Monitor-
ing of the Infection. Mice were challenged by intraperitoneal
injection of 1 × 106, 5 × 106, or 25 × 106 live NC-Liv
tachyzoites in 0.5mL 0.04M isotonic PBS. Mice were then
closely monitored daily for neosporosis disease symptoms
according to a clinical scoring system that included hunched
back, rough hair coat, impairedmovement, and spinning. For
each feature a mouse obtained a score of 1, the maximal score
being 4.The average clinical score per group was determined
by dividing the total score per group by the amount of mice
in that group. As soon as the health status of the animals
deteriorated, the frequency of observations was increased to
two times a day.Weight loss wasmeasured three times a week
during the entire experimental period. Moribund mice or
mice with severe neurobiological symptoms were euthanized
(humane endpoint).
Blood samples were collected by orbital puncture at day
0 and day 34 postinfection (at the time of euthanasia) or,
whenever possible, at the time of inter-current death. Prior
to blood sampling and euthanasia, mice were subjected to
anaesthesia by isoflurane. Latest at day 34 postinfection (PI),
surviving mice were sacrificed by cervical dislocation and
brains and spleens were harvested. For eachmouse, one brain
hemisphere was stored at −20∘C for further DNA extraction.
The other half was fixed in 10% neutral buffered formalin
for histopathology. Spleens were immediately processed as
described below.
2.4. Histopathology. Formalin-fixed material was processed
into paraffin wax. Sections of 3.5 𝜇m thickness were cut
longitudinally from nervus I to medulla oblongata with
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cerebrum, hippocampus, and cerebellum on a BrandMicrom
H355 S microtome (Adamas, Rhenen,The Netherlands), and
were placed onto glass slides. Sections were stained with
haematoxylin-eosin.
2.5. Serological Analysis. Serum antibody levels were anal-
ysed using a commercially available ELISA kit based on
antigens of N. caninum (IDEXX Neospora Ab Test, IDEXX
Laboratories, Westbrook, USA) according to the instructions
of the manufacturer. On each plate, sera were tested in
2log titrations, and negative and positive sera were tested in
octaploid. Sera of naı¨ve Swiss outbred mice (Charles River,
Sulzfeld, Germany) were used as a negative control. As a
positive control for IgG1 and IgG2a detection, sera of BALB/c
mice vaccinated with the chimeric antigen R-MIC3-1 and
challenged with N. caninum (NC-1 isolate) tachyzoites were
used [2, 3]. Sera of C57BL/6mice taken 34 days after infection
with 5 × 106 NC-Liv tachyzoites were used as a positive
control for IgG2c analysis. Horseradish-peroxidase-(HPR-)
conjugated goat antimouse IgG1, IgG2a, and IgG2c were
obtained from Southern Biotechnology (Birmingham, USA)
and diluted in enzyme immune assay (EIA) buffer containing
0.05% polysorbate 80. Results were analysed on a Tecan
SUNRISE device (Breda, The Netherlands) using XFluor4
Software at 650 nm. Antibody titres were determined using
CaSpEx Software; AbendVertical version 0.11 V1 (MSD Ani-
malHealth, Proprietary Software).The cutoff in antibody end
titres was defined at Bmin ∗ 2, where Bmin is the negative
control.
2.6. Lymphocyte Proliferation Assay and Cytokine Measure-
ments. Spleens from surviving mice were washed twice in
RPMI 1640 medium supplemented with 100.000 IU peni-
cillin/streptavidin, 1mM sodium-pyruvate, and 2mM L-
glutamine and dissociated using the gentleMACSDissociator
(Miltenyi Biotec, Leiden, The Netherlands) according to the
instructions of the manufacturer. Suspensions were filtered
through a 100𝜇m cell strainer and centrifuged at 300×g for
10min at 4∘C. Samples were depleted of erythrocytes with
erythrocyte lysis solution containing 829 g/L ammonium
chloride, 100 g/L sodiumhydrogen carbonate, and 3.7 g/L dis-
odiumedetate. Splenocytes frommice of the same groupwere
pooled in a 1 : 1 ratio and a total of 1×105 splenocyteswere cul-
tured for 72 hrs in 100 𝜇L complete RPMImedium containing
10% FBS in a humidified incubator at 37∘C with 5% CO
2
.
100 𝜇Lof an antigenic extract of either 2×104, 1×105, or 5×105
NC-Liv tachyzoites prepared as described abovewas added to
the cells. Complete RPMImediumand a phorbolmyristateac-
etate (PMA)/ionomycinmixture (9.74 ng/mL/0.26mM)were
used as negative and positive controls, respectively. Cytokine
levels in supernatants of stimulated splenocytes were ana-
lyzed using the BenderMedSystems FlowCytomixMouse/Rat
Basic Kit combined with the cytokineMouse Simplex Kits for
IFN-𝛾 (BenderMedSystems,Vienna, Austria). Cytomix assays
were performed according to the instructions of the manu-
facturer. Results were analyzed using the BenderMedSystems
FlowCytomix Pro 2.4 Software. The samples of the cytomix
assay were interpolated in the standard curve by selecting the
5P logistic fit function: the BenderMedSystems FlowCytomix
Pro 2.4 Software fits the best curve according to 𝑦 =
𝑑 + ((𝑎 − 𝑑)/(1 + (𝑥/𝑐)
𝑏
)
𝑔
). The mean fluorescence intensity
(MFI) of each standard point is blank-corrected by division
of the Blank-MFI (B B0 = MFI/MFI of Blank∗100). The
maximum acceptable bias, which displays the variation for
the ideal standard curve defined by the theoretical standard
concentrations, was set at 30%.
2.7. PCR Analysis in Brain Tissue. Neospora-specific quanti-
tative real-time PCR to determine the number of tachyzoites
that has reached the cerebral tissue was performed as previ-
ously described [2, 3, 15]. DNA extraction from brain tissue
was performed using theDNeasy Blood&TissueKit (Qiagen,
Hilden, Germany) according to the manufacturer recom-
mendations. The DNA concentration in each sample was
determined by UV spectrophotometry (NanoDrop, Thermo
Scientific, Delaware, USA) and was adjusted to 5 ng/𝜇L
with sterile DNase-free water. Quantitative real-time PCR
was performed using the Light Cycler Instrument (Roche
Diagnostic, Basel, Switzerland). The parasite counts were
calculated by interpolation from a standard curve with DNA
equivalents from 1000, 100, and 10 parasites included in each
run.
2.8. Statistics. Mice survival was analyzed according to
Kaplan-Meier and the survival curves between groups were
compared with the logrank test followed by regression coeffi-
cient analysis. The weight of the survivors, cerebral parasite
burden, lesion score, and the serological data were com-
pared using Kruskal-Wallis one-way ANOVA followed by the
Kruskal-Wallismultiple comparison𝑍-value test.The𝑃 value
between two significantly different groups was calculated
by Mann-Whitney 𝑈 test. The proportion of animals with
clinical signs, proportion of animals with brain lesions and
data onN. caninum-DNA-positive animals were organized in
a contingency table and compared by a Chi-square test.
3. Results
3.1. Clinical Observations. BALB/c mice (Figures 1(a) and
1(b)) challenged with 1 × 106 tachyzoites were not affected,
with no decrease in body weight following infection. How-
ever, challenge with 5 × 106 NC-Liv tachyzoites resulted in
neosporosis symptoms in BALB/c mice, starting on day 18
PI. Hunched back, ruffled coat, and weight loss of ∼25%
were observed in these mice. Two mice reached the point
where severe neurobiological symptoms made it necessary
to get them euthanized on day 23 PI, while the other
three mice, although exhibiting clinical symptoms, but less
severe, survived throughout the observation period of 34 days
(Figures 1(a) and 1(b)). BALB/c mice were not able to control
the highest infectious dose of 25 × 106 tachyzoites, resulting
in death of all five animals within that group between days 7
and 12 PI.
CBA/Ca mice (Figures 1(c) and 1(d)) exhibited a high
degree of resistance against N. caninum at an infection dose
of 1 × 106 and 5 × 106 tachyzoites, with no mortality and no
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(f) Body weight changes in C57BL/6 mice
Figure 1: Mean groupmorbidity scores ((a), (c), and (e)) andmean weight changes ((b), (d), and (f)) in BALB/c, CBA/Ca, and C57BL/6 mice
following i.p. inoculation with 1 × 106, 5 × 106, or 25 × 106 NC-Liv tachyzoites. Mice were scored for clinical symptoms including hunched
back, ruffled hair coat, impaired movement, and spinning when picked up by the tail, resulting in a maximum clinical score per mouse of 4.
Figures 1(a), 1(c), and 1(e) show the average clinical score per mice per group. ∗indicate the death of a mouse; error bars ± SD; 𝑛 = 5.
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Figure 2: Survival plot of mice 34 days after challenge with NC-Liv
tachyzoites.
body weight changes during the entire experimental period
(Figures 2 and 1(d)). However, none of the CBA/Ca mice
could control the infection at the highest dose and they all
were euthanized within 9 days PI (Figures 1(c) and 1(d)).
In comparison to the other two mouse strains, C57BL/6
mice (Figures 1(e) and 1(f)) were the most sensitive. At an
infection dose of 1×106 tachyzoites, all mice started to exhibit
clinical symptoms including weight loss of ∼10% and two out
of five mice had to be euthanized at day 29 PI (Figure 2).
Strong variations were observed in the group of C57BL/6
mice challenged with 5 × 106 tachyzoites. Three mice of this
group demonstrated severe symptoms of neosporosis and
were euthanized on days 7, 8 and 13 PI, while the other
two mice showed only very mild symptoms on day 8 PI
and returned to being clinically normal 9 days after the
challenge. Shortly after a challenge with 25 × 106 tachyzoites,
C57BL/6 mice showed a hunched back and ruffled hair
coat (Figures 1(e) and 1(f)). Symptoms progressed to include
impaired movements and spinning when picked up by the
tail, requiring euthanasia of four of these mice on day 8 PI.
The remaining mouse of this group completely recovered by
day 11 PI and survived till the end of the experiment.
Statistically, CBA/Camice exhibited a significantly higher
survival rate than C57BL/6 mice at an infection dose of
1 × 10
6 tachyzoites (𝑃 < 0.001, Cox regression analysis)
and than C57BL/6 and BALB/c mice at an infection dose of
5 × 10
6 tachyzoites (𝑃 < 0.001, Cox regression analysis). The
mean weight of the survivors of the BALB/c mice infected
with 1 × 106 tachyzoites was slightly higher than those
infected with 5 × 106 parasites, although the difference was
not significant (Kruskall-Wallis multiple comparison test).
The number of symptomatic mice in the CBA/Ca mice at
an infection dose of 5 × 106 tachyzoites was significantly
lower than in the two other groups (𝑃 < 0.01, Chi-square
test) while no significant differences between strains were
observed for the other infection doses (Table 2). The number
of mice presenting brain lesions as well as the lesion score
per group at an infection dose of 5 × 106 parasites was
significantly lower in the CBA/Ca mice (𝑃 < 0.01, Chi-
square test and 𝑃 < 0.001, Mann-Whitney 𝑈-test, resp.) than
in the two other groups (Table 2). No significant difference
was observed regarding the overall lesion score per strain
(Table 2). Moreover, C57BL/6 mice showed strong variations
within each group.
The surviving BALB/c mice infected with 1 × 106 tachy-
zoites (𝑛 = 5) and CBA/Ca mice infected with 5 × 106
tachyzoites (𝑛 = 5) were challenged again with 25 × 106 N.
caninum tachyzoites at day 34. However, they all succumbed
to infection within 24 hrs, indicating that they had not built
up any form of protective immunity.
3.2. Serology. In order to obtain information on the type
of immune response induced by N. caninum infection, the
serum titres of N. caninum-specific IgG1 and IgG2a antibod-
ies were recorded. The production of IgG1-type antibodies is
primarily induced by a humoral immune response, whereas
IgG2a subclasses indicate the involvement of a cellular
immune response. SinceC57BL/6mice poorly produce IgG2a
antibodies, the IgG2c levels were measured in serum of
these mice. In none of the groups N. caninum-specific
antibodies were detected prior to challenge (data not shown).
Experimental infection of BALB/cmice with 1×106 or 5×106
tachyzoites resulted in high IgG2a and IgG1 serum levels,
indicating the presence of a mixed cellular and humoral
immune response (Table 1). In CBA/Ca mice challenged
with 1 × 106 or 5 × 106 tachyzoites, predominantly IgG2a
antibodies were detected. IgG2a and IgG1 were undetectable
in CBA/Ca mice challenged with 25 × 106 tachyzoites, most
likely because mice succumbed to the infection before a
humoral response was mounted (Table 1). C57BL/6 mice
exhibited high variations in IgG1 and IgG2c serum levels.
In general, sera of mice surviving until day 34 PI contained
higher levels of IgG2c compared to sera of their group mates
that died at earlier time points (Table 1). The difference
IgG2a/c-IgG1 postinfection was highly significantly higher
in the CBA/Ca mice than in the two other strains (𝑃 <
0.01, Mann-Whitney 𝑈-test) and significantly higher in the
C57/BL6 mice than in the BALB/c mice (𝑃 < 0.05, Mann-
Whitney 𝑈-test) at an infection dose of 1 × 106 parasites.
At an infection dose of 5 × 106 tachyzoites, both CBA/Ca
and C57/BL6 mice had a significantly higher IgG2a/c-IgG1
difference than the BALB/c mice (𝑃 < 0.01, and 𝑃 < 0.05
respectively, Mann-Whitney 𝑈-test), and CBA/Ca mice also
had a higher IgG2a/c-IgG1 difference thanC57/BL6, although
not significant (Table 2 and Figure 4).
3.3. Stimulation of Spleen Cells of Selected Survivors and IFN-
𝛾 Production upon Recall Responses. The production of IFN-
𝛾, indicating the occurrence of a cellular immune response,
wasmeasured in the supernatants of spleen cells derived from
survivors of BALB/c mice (infected with 5 × 106 tachyzoites),
CBA/Ca mice (infected with 1 × 106 tachyzoites), and all
surviving C57BL/6 mice. Splenocytes were stimulated with
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Table 1: IgG2a or IgG2c and IgG1 titres were measured at the time of death or euthanasia (intercurrent death) or at the end of the experiment
at day 34 PI. For calculation, the value “4.5” was chosen when the titre was below the detection limit (<5.0).
Experimental groups Antibodies at day 34 or time of euthanization (2log)
Mouse number Survival time (days)
Inbred strain Challenge dose IgG2a/c IgG1 IgG2a/c-IgG1
1.1 34 13.6 11.2 2.4
1.2 34 14.1 11.0 3.1
BALB/c 1 × 106 1.3 34 13.0 11.6 1.4
1.4 34 14.1 14.4 −0.3
1.5 34 14.7 15.4 −0.7
2.1 34 14.6 14.6 0.0
2.2 34 14.8 15.8 −1.0
BALB/c 5 × 106 2.3 34 14.5 14.7 −0.2
2.4 23 14.4 13.3 1.1
2.5 23 15.0 14.0 1.0
3.1 8 — — —
3.2 12 — — —
BALB/c 25 × 106 3.3 8 9.9 7.7 2.2
3.4 12 9.4 8.3 1.1
3.5 7 — — —
4.1 34 10.8 4.5 6.3
4.2 34 14.8 6.5 8.3
CBA/Ca 1 × 106 4.3 34 11.0 6.7 4.3
4.4 34 11.2 4.5 6.7
4.5 34 13.9 9.8 4.1
5.1 34 12.2 6.0 6.2
5.2 34 13.1 5.1 8.0
CBA/Ca 5 × 106 5.3 34 13.3 9.2 4.1
5.4 34 13.5 9.6 3.9
5.5 34 13.6 12.2 1.4
6.1 9 5.0 4.5 0.5
6.2 9 6.0 6.9 −0.9
CBA/Ca 25 × 106 6.3 8 — — —
6.4 9 5.7 4.5 1.2
6.5 9 4.5 4.5 0.0
7.1 34 13.4 9.8 3.6
7.2 34 14.9 14.6 0.3
C57BL/6 1 × 106 7.3 29 14.1 10.8 3.3
7.4 29 12.9 7.1 5.8
7.5 34 14.6 9.2 5.4
8.1 13 10.1 4.5 5.6
8.2 7 4.5 4.5 0.0
C57BL6 5 × 106 8.3 34 15.6 13.4 2.2
8.4 8 10.5 4.5 6.0
8.5 34 16.5 13.7 2.8
9.1 8 10.7 6.9 3.8
9.2 8 7.4 4.5 2.9
C57BL6 25 × 106 9.3 34 15.6 14.5 1.1
9.4 8 7.7 4.5 3.2
9.5 8 8.5 4.5 4.0
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Table 2: Experimental groups, numbers of symptomatic mice, and numbers of parasites in brain and brain lesion scores at the time of death
or euthanasia (intercurrent death) or at the end of the experiment at day 34 PI.The detection limit of the PCR is 10 parasites/reaction. Lesions
were graded using the following system: (0) no lesions, (1) light positive or small foci, (2) moderately positive, (3) severely positive with large
inflammatory process, ∗tachyzoites, and ∗∗cyst.
Experimental groups
(𝑛 = 5)
Number of
symptomatic mice
Time of death
(day PI)
Number of parasites in 20 ng
brain DNA (real-time PCR)
Brain lesion score
(histopathology)
1 × 106 0 34, 34, 34, 34, 34 0, 0, 0, 361, 300 0, 0, 0, 1, 0
BALB/c 5 × 106 5 34, 34, 34, 34, 23 464, 651, 488, 902, 1183 0, 2, 1, 1, 2
25 × 106 5 8, 12, 8, 12, 7 587, 763, 260, ND, 154 0, 0, 0, 0, 0
1 × 106 0 34, 34, 34, 34, 34 0, 0, 0, 0, 156 3∗, 0, 0, 2, 0
CBA/Ca 5 × 106 0 34, 34, 34, 34, 34 0, 0, 0, 0, 0 0, 0, 0, 0, 0
25 × 106 5 9, 9, 8, 9, 9 466, 433, 349, 606, 593 0, 0, 1, 1, 2
1 × 106 2 34, 34, 29, 29, 34 0, 177, 525, 0, 763 0, 0, 1, 1, 2
C57BL/6 5 × 106 5 13, 7, 34, 8, 34 312, 0, 638, 0, 879 3∗∗, 0, 2, 0, 3
25 × 106 5 8, 8, 34, 8, 8 344, 325, 788, 232, 0 0, 0, 2, 0, 0
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Figure 3: IFN-𝛾 production by stimulated splenocytes derived
from BALB/c, CBA/Ca, and C57BL/6 mice challenged with varying
doses of Nc-Liv tachyzoites. The IFN-𝛾 production was analyzed in
triplicates. Results show the mean values ± SD.
either N. caninum antigens or PMA/ionomycin for 72 hrs, or
were left unstimulated. Stimulation with a lysate correspond-
ing to 2 × 104, 1 × 105 or 5 × 105 purified NC-Liv tachyzoites
resulted in increased production of IFN-𝛾. IFN-𝛾 production
was a dose-dependent stimulus in all groups (Figure 3). The
strongest IFN-𝛾 response was observed for the CBA/Camice,
as was especially evident using low and medium tachyzoite
stimulus doses. A lower IFN-𝛾 production was observed
for the BALB/c mice, while splenocytes from C57BL/6 mice
demonstrated large variations in IFN-𝛾 production upon
antigen stimulation. Data from BALB/c mice and CBA/Ca
mice infected with 25 × 106 parasites is missing, since these
mice succumbed to infection prior to 34 days postinfection.
Spleen cells of BALB/c mice infected with 1 × 106 tachyzoites
(𝑛 = 5) and CBA/Ca mice infected with 5 × 106 tachyzoites
(𝑛 = 5), which were used for rechallenge, were not assessed.
3.4. PCR Analysis in Brain Tissue and Comparison with
Histopathology. The cerebral parasite load in all groups was
measured by real-time PCR and compared with histopatho-
logical findings. Corresponding results are summarized in
Table 2. In three out of five BALB/c mice challenged with
1 × 10
6 tachyzoites, no parasite DNA could be detected by
PCR, while high numbers were detected in the other two
samples. However, in only one of these mice a brain lesion
was detected by histology. Challenge of BALB/c mice with
5×10
6 tachyzoites resulted in high cerebral parasite load in all
mice, and brain lesions were detected upon histopathological
inspection in four out of five mice. After infection of BALB/c
mice with 25 × 106 tachyzoites, parasites were detected at
moderate to high numbers in all brain samples investigated,
but histopathology failed to detect any lesions at all.
Real-time PCR detected N. caninum DNA in one of 10
brain samples of CBA/Ca mice challenged with 1 × 106
and 5 × 106 tachyzoites. In contrast, lesions were observed
by histopathological means in two mice infected with 1 ×
10
6 tachyzoites. However, these were samples that were not
positive by real-time PCR. In the CBA/Ca mice infected with
25 × 10
6 tachyzoites, lesions in the central nervous system
(CNS) were observed by histopathology for three out of five
animals, and real-time PCR showed high numbers of parasite
load in all 5 members of the group, which all died between
days 8 and 9 PI.
In three C57BL/6 mice challenged with 1×106 tachyzoite
lesions in the brain were observed. In two of them parasites
were measured 29 days PI. Infection with 5 × 106 tachyzoites
resulted in parasites and lesions in three mice on days 13 and
34 PI. In the C57BL/6mice infected with 25×106 tachyzoites,
four out of five mice died 8 days after challenge, with
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Figure 4: Difference between IgG2a or IgG2c and IgG1 levels in postinfection sera. (a) Infection dose of 1×106 tachyzoites. (b) Infection dose
of 5×106 tachyzoites. ∗Indicates a statistically significant difference between the groups (𝑃 < 0.05). ∗∗Indicates a highly significant difference
between the groups (𝑃 < 0.01).
real-time PCR-positive brain tissue but no lesions detectable
upon histopathology. One mouse survived until day 34 PI,
and this mouse exhibited a high cerebral parasite load and
also brain lesions. Thus, a high cerebral parasite load as
determined by real-time PCR did not always correspondwith
the detection of lesions in the brain and did also not always
match with the occurrence of clinical signs of neosporosis.
At an infection dose of 1 × 106 and 25 × 106 tachyzoites, no
significant difference in the number of PCR positive mice
between the groups was observed (Chi-square test). At an
infection dose of 5 × 106 tachyzoites, the number of PCR-
positive mice was significantly lower in the CBA/Ca mice
than in the BALB/c and C57/BL6 mice (𝑃 < 0.01 and 𝑃 <
0.05, respectively, Chi-square test). No significant difference
regarding the parasite load of infected mice was observed
between the groups (Kruskal-Wallis multiple comparison
test).
4. Discussion
In this study, we compared the capacities of three inbred
mouse strains expressing different MHC-I molecules to cope
with a N. caninum infection. Significant differences in the
responses to N. caninum infection in inbred and outbred
mice have been demonstrated previously [16], and these
differences have been postulated to be due to varying abilities
to presentN. caninum antigens on theirMHCmolecules [17].
When using mouse models to investigate the outcome and
immunological parameters of infection, the selection of the
N. caninum isolate as well as inoculum doses are important
variables that will influence the results [16].The present study
showed high variations in morbidity and mortality in the
three inbred mouse strains BALB/c, CBA/Ca, and C57BL/6
after inoculation with different numbers of N. caninum
(NC-Liv) tachyzoites, demonstrating that the choice ofmouse
strain plays a crucial role for the assessment of experimental
infections and agents that could potentially interfere therein.
While BALB/c mice did not suffer from clinical signs of
neosporosis after a challenge dose of 1 × 106 N. caninum
tachyzoites, infection with 5 × 106 tachyzoites resulted in
severe clinical symptoms starting at day 20 PI. Also C57BL/6
mice were highly susceptible to experimental infection
with N. caninum tachyzoites. This is in accordance with
several vaccination studies, which have used the BALB/c
and C57BL/6 models to investigate the protective effects of
vaccine candidates (reviewed in [2, 3]). In contrast, only
limited research has been performed using CBA/Ca mice
as a model to investigate the immune responses against N.
caninum infection. Our investigations demonstrated that this
mouse strain is clearly more resistant against neosporosis
compared to BALB/c and C57BL/6 mice. Previously, these
features of CBA/Camice with regard toN. caninum infection
had been highlighted by Rettigner et al. [18], who described
this mouse strain to be resistant against an infection of 5 ×
10
6 tachyzoites of the NC-1 isolate of N. caninum following
treatment with immunosuppressing agents and suitable for
the generation of cerebral tissue cysts.This is surprising, since
the NC-1 isolate, in contrast to NC-Liv, does hardly convert
into bradyzoites under in vitro conditions such as high pH
treatment or incubation with sodium nitroprusside [19, 20].
With respect to C57BL/6 mice, Ramamoorthy et al. [21]
observed no clinical signs of neosporosis throughout an
observation period of 21 days after an infection with 5 ×
10
6 NC-1 tachyzoites but also showed these mice to be highly
susceptible to an infection with 2 × 107 NC-1 tachyzoites.
Others failed to observe clinical signs in C57BL/6 mice after
a challenge with 5 × 106 NC-1 tachyzoites as long as 44 days
PI [22]. In this study, after a challenge dose of 1 × 106 NC-
Liv tachyzoites disease symptoms occurred after 26 days but
only after 8 days when 5 × 106 tachyzoites were inoculated,
with three out of five mice succumbing to infection. This
illustrates that, besides themouse strain used, the selection of
the Neospora isolate also makes a big difference. In any case,
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an infection dose of 25×106 tachyzoites of the NC-Liv isolate
was far too high for any of the mouse strains to cope with,
requiring euthanasia of all but one mouse between days 7–12
PI.
Since N. caninum is an intracellular parasite, the pro-
tective immune response is likely to involve cell-mediated
immunity; thusTh1-mediated responses are important. How-
ever, in BALB/c mice it has been demonstrated that besides
cellular immunity also humoral immune responses are cru-
cial in controlling N. caninum infection and limiting the
pathological changes caused by an excessive proinflamma-
tory response [23, 24]. Teixeira et al. [25] described that
intraperitoneal injection of N. caninum tachyzoites (NC-1
isolate) in BALB/cmice induced a parasite-specific, nonpoly-
clonal, B-cell response. A strong bias towards a Th2-type
response resulted in increased susceptibility to N. caninum
and enhanced the corresponding pathologic effects [26].
However, vaccination of mice with recombinant rhoptry
antigen ROP2 emulsified in saponin adjuvants induced
an IgG1-biased humoral immune response, while formu-
lating the same antigen in Freund’s incomplete adjuvants
resulted in an IgG2a-biased antibody response, and both
were protective in the nonpregnant BALB/c mouse model.
Protection associatedwith an IgG2a-biased humoral immune
response was also demonstrated for recombinant protein
disulfide isomerase applied for vaccination intranasally [27–
29]. Vaccination of mice with native NcSRS2 induced a Th2-
biased protective response that reduced congenital infection
of offspring BALB/cmice [30]. Reduction in congenital infec-
tion, also associated with a Th2-biased immune response,
was demonstrated by vaccination experiments in BALB/c
mice employing combined NcMIC1, NcMIC3, and NcROP2
antigens [31]. Taken together, it is probably rather a suitable
balance in Th1/Th2-type immune responses than a strict
Th1 response that allows the host to deal with N. caninum
infection [23].
Similar to earlier studies in BALB/c mice [25, 26], levels
of IgG1 antibodies in animals infected with 1 × 106 and 5 ×
10
6 tachyzoites were generally high, and it is interesting to
note that a challenge dose of 5 × 106 tachyzoites in BALB/c
mice resulted in more pronounced IgG1 responses compared
to the IgG1 antibody levels found in mice inoculated with
1 × 10
6 tachyzoites, while IgG2a titres were basically equal
in both groups. In the BALB/c mice inoculated with 5 × 106
tachyzoites, titres for IgG1 and IgG2a were similar, which is
in agreement with previous observations reported by Lunde´n
et al. [32]. In addition, we found that splenocytes obtained
from BALB/c mice inoculated with 5 × 106 tachyzoites and
stimulated with N. caninum antigen produced IFN-𝛾, albeit
at a lower level compared to CBA/Ca mice. The results of
Rettigner et al. [18] on N. caninum infection in CBA/Ca
mice showed no evidence of differential isotype secretion but
a high expression of IFN-𝛾, while in our experiments sera
of infected CBA/Ca mice exhibited a high IgG2a response,
and splenocytes of CBA/Ca mice infected with 1 × 106 N.
caninum tachyzoites also secreted high levels of IFN-𝛾. This
indicated that the induction of a cellular immune response is
a prerequisite for successful dealing with the infection.
The importance of the humoral immune response during
N. caninum infection was demonstrated by Eperon et al.
[22] who showed increased susceptibility to N. caninum
(NC-1 isolate) infection in 𝜇MT B-cell-deficient mice when
compared to wild-type C57BL/6 mice. They also described
the predominant presence of parasite-specific IgG2a isotypes
and an absence of IgG1 isotypes in C57BL/6 mice at various
time points. In contrast to Eperon et al., we did not observe
any IgG2a antibody titres in C57BL/6 mice and analysed the
IgG2c antibody isotype levels instead. Our results showed the
major parasite-specific IgG isotype to be IgG2c. In agreement
with a shift from a Th1- to a Th2-biased response, increasing
titres of N. caninum-specific IgG1 were detected in mice sera
collected at later time points after infection. However, in our
hands the C57BL/6 mice exhibited considerable variability.
WhileN. caninum obviously induces differential humoral
and cellular immune responses in different mouse strains
during the acute phase of infection, one could imagine that
chronic infection would be characterized by the production
of tissue cysts. Vertical transmission in cattle is mediated by
recrudescence of tissue cysts. Therefore, in order to mimic
the infection in cattle, a mouse model able to form tissue
cysts, and also exhibiting recrudescence during pregnancy,
is required. However, only few reports have actually been
published on the production of N. caninum tissue cysts in
mice. Tissue cyst production had been demonstrated in out-
bred mice and immunosuppressed CBA/Ca mice inoculated
with NC-1 or NC-Liv tachyzoites but not all of the mice
investigated harboured cerebral tissue cysts and the rate of
mortalitywas high (31%) [33]. Rettigner et al. [18] showed that
immunosuppressed female CBA/Ca mice given 5×106 NC-1
tachyzoites were able to survive and to consistently develop
cerebral tissue cysts. More recently, tissue cyst production,
marked by positive stainingwith an antibody directed against
the Toxoplasma bradyzoite antigen BAG5, has also been
demonstrated in an experimentally infected carnivorous
marsupial, the fat-tailed dunnart Sminthopsis crassicaudata
[34]. It is also very likely that N. caninum tissue cysts are
not necessarily formed predominantly in the CNS but also at
other locations such as muscle tissue [34, 35], and this should
be taken into account in future studies.
In conclusion, we comparatively assessed BALB/c,
CBA/Ca, and C57BL/6 mice as models for N. caninum
infection and demonstrated that CBA/Ca mice exhibited the
highest degree of resistance at low and medium infection
doses but rapidly developed acute signs of neosporosis when
challenged with the highest dose of N. caninum NC-Liv
tachyzoites. In addition, CBA/Ca mice induced a strong
cellular immune response. This mice strain has previously
been shown to be suitable for tissue cyst production [18],
which renders them an interesting model for investigations
on protective effects and potential tools for vaccination.
In contrast, the use of BALB/c mice, although extensively
employed, is debatable due to their inherent Th2 bias,
resulting in increased susceptibility to N. caninum. Highly
variable results have been obtained using C57BL/6 mice as
model. Thus, there is clearly a need for a standardisation of
experimental murine infection models for N. caninum in
10 ISRN Parasitology
order to achieve comparable results between research groups
that work with different tools for immunoprevention and
chemotherapy.
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